MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...

The Global Peptic Ulcer Drugs Market size is expected to be worth around USD 6.4 Billion by 2032 from USD 4.8 Billion in 2023, growing at a CAGR of 3.5% during the forecast period from 2023 to 2032.

The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

Alex Sigmund, DVM, DACVO, shares fallacies surrounding these eye conditions in pets, including the role of antibiotics in ...

The clinical features, etiology, and treatment of recurrent aphthous ulcers (RAU) are discussed. Aphthous ulcers are among the most common oral lesions in the general population, with a frequency ...

Lucknow: Varicose veins can lead to severe pain and complications if left untreated, said experts during a continuing medical ...

All p values apply to comparisons between active treatment and placebo unless otherwise indicated. b Mean number of new ulcers, compared with baseline. c Mean score on a scale from 0 to 3 (0 = no ...

Just because you can buy a medication over the counter doesn’t mean it’s always safe. Here’s how you should really be using ...

Medically reviewed by Qin Rao, MD Pill esophagitis, or drug-induced esophagitis, occurs when oral medications cause ...

By repositioning existing drugs for new clinical indications ... Some examples include cimetidine, originally an anti-peptic ...